Perspective · 10 Sep 2026
CommentaryPublished 22 Sep 2020
Elective Surgery at the Time of COVID-19 Pandemic: The Forgotten Gallstone Disease
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
SARS-CoV-2 dramatically affected the quality of life of millions of people worldwide. The healthcare systems are rearranging their resources to pursue surgical activity, but delays were inevitably expected, especially for benign hepato-biliary-pancreatic disease, such as gallstone disease. To analyze the entity of the COVID-19 related effects on surgical activity for cholelithiasis, surveys were distributed to surgeons in different institutions across the world. Data showed that beds of intensive care units were mainly dedicated to SARS-CoV-2 patients. COVID-19 infections also affected part of the health caregivers, sometimes not adequately trained to the new operating room settings. As a consequence, elective surgeries for gallstone diseases which represents one of the most common surgical procedures-were postponed, and medical treatments were preferred whenever possible, resulting in high risk of developing gallstones disease-related morbidity. An alarming decrease of laparoscopic cholecystectomies was recorded, unless emergency situations were encountered. The COVID-19 pandemic significantly decreased the surgical management of different diseases, such as gallstone disease, resulting in a huge number of untreated patients who could develop severe morbidity. Day surgery and ambulatorial procedures could provide effective solutions to face the current emergency situation, as well as specific dedicated COVID-19-free pathways for patients affected by benign surgical diseases.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Angelico Roberta”
- BylineArticles whose byline prints “Gazia Carlo”
- BylineArticles whose byline prints “Manzia Tommaso Maria”
